Evaluation of Predictive Factors for Psoas Tendinitis After First-line Total Hip Arthroplasty
NCT ID: NCT05029648
Last Updated: 2024-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1199 participants
OBSERVATIONAL
2011-08-11
2024-06-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A single-centre retrospective study of medical data from the medical records of patients undergoing total hip arthroplasty.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study on Radiological Factors Predictive of Psoas Impingement
NCT05893823
Clinical Improvement Obtained by Endoscopic Ilio-Psoas Tenotomy (Lesser Trochanter Versus Acetabular Notch)
NCT05950022
Clinical Trial of Concomitant Hip Arthroscopy During PAO
NCT03181048
Immediate Post-THA Functional Assessment
NCT04928924
Psoas Tenotomy Under Ultrasound
NCT06064136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Main objective: To assess individual and surgical factors associated with the development of psoas tendinitis.
Secondary objectives:
* To describe the frequency of occurrence of psoas tendinitis
* To describe the outcome of patients who underwent tenotomy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
Simple cohort
Cohort
Cohort
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cohort
Cohort
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who has had a total hip replacement implanted for at least six months as a first-line treatment
* Patient who has been regularly monitored since the operation and for whom all clinical and radiological data are available during follow-up visits
Exclusion Criteria
* Patient who has indicated his opposition to the use of his medical data
* Patient under legal protection, guardianship or curators
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GCS Ramsay Santé pour l'Enseignement et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolas BONIN, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique de la Sauvegarde
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique de la Sauvegarde
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COS-RGDS-2019-12-054
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.